Cargando…

Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma

BACKGROUND: To explore clinical features and prognostic value of vascular endothelial growth factor (VEGF), interleukin (IL) 8, IL-10, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and receptor-interacting protein-2 (RIP2) in diffuse large B-cell lymphoma (DLBCL)....

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Na, Yu, Yanfang, Zhang, Ruiying, Guo, Ying, Liu, Mei, Tan, Mengtian, Liu, Jianxia, Bai, Jing, Li, Li, Liu, Keyu, Wang, Ran, He, Jinglan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750766/
https://www.ncbi.nlm.nih.gov/pubmed/36567775
http://dx.doi.org/10.1155/2022/2637581
_version_ 1784850329040322560
author Shen, Na
Yu, Yanfang
Zhang, Ruiying
Guo, Ying
Liu, Mei
Tan, Mengtian
Liu, Jianxia
Bai, Jing
Li, Li
Liu, Keyu
Wang, Ran
He, Jinglan
author_facet Shen, Na
Yu, Yanfang
Zhang, Ruiying
Guo, Ying
Liu, Mei
Tan, Mengtian
Liu, Jianxia
Bai, Jing
Li, Li
Liu, Keyu
Wang, Ran
He, Jinglan
author_sort Shen, Na
collection PubMed
description BACKGROUND: To explore clinical features and prognostic value of vascular endothelial growth factor (VEGF), interleukin (IL) 8, IL-10, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and receptor-interacting protein-2 (RIP2) in diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 68 DLBCL patients admitted to the Affiliated Hospital of Hebei Engineering University from January 2017 to June 2021 were included in this retrospective analysis. Serum VEGF was detected by enzyme-linked immunosorbent assay, serum IL-8 and IL-10 were detected by chemiluminescent enzyme immunoassay, and expression of PIK3CA and RIP2 in tumors was detected by immunohistochemistry. The correlation between clinical features of DLBCL and tumor-related index were analyzed. Cox regression was conducted to explore risk factors and hazard ratio. RESULTS: The serum level or expressions of VEGF, IL-8, IL-10, and RIP2 were significantly elevated with the increase of Ann Arbor Stage, International Prognostic Index (IPI) scores, Eastern Cooperative Oncology Group (ECOG) scores, serum lactate dehydrogenase (LDH) level, and the number of extranodal sites (all P < 0.05). Beside, these serum indexes were significantly higher in patients with the presence of extranodal involvement and germinal center B-cell (GCB), but significantly lower in patients with the presence of bone marrow involvement (all P < 0.05). Cox regression analysis for overall survival revealed that high expression of VEGF, high level of serum IL-8, serum IL-10, and RIP2, Ann Arbor Stage (III-IV), number of extranodal sites (>1), serum LDH level (≥245 U/L), IPI scores (3–5), ECOG scores (≥2), and bone marrow involvement were independent risk factors for the prognosis of DLBCL patients (all P < 0.05). CONCLUSION: The serum levels of VEGF, IL-8, and IL-10, as well as the expression of RIP2 and PIK3CA in tumor tissues, were highly correlated to clinical features of DLBCL, and high expression level of these indexes may have adverse effects for the prognosis of DLBCL patients.
format Online
Article
Text
id pubmed-9750766
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-97507662022-12-23 Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma Shen, Na Yu, Yanfang Zhang, Ruiying Guo, Ying Liu, Mei Tan, Mengtian Liu, Jianxia Bai, Jing Li, Li Liu, Keyu Wang, Ran He, Jinglan Int J Clin Pract Research Article BACKGROUND: To explore clinical features and prognostic value of vascular endothelial growth factor (VEGF), interleukin (IL) 8, IL-10, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and receptor-interacting protein-2 (RIP2) in diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 68 DLBCL patients admitted to the Affiliated Hospital of Hebei Engineering University from January 2017 to June 2021 were included in this retrospective analysis. Serum VEGF was detected by enzyme-linked immunosorbent assay, serum IL-8 and IL-10 were detected by chemiluminescent enzyme immunoassay, and expression of PIK3CA and RIP2 in tumors was detected by immunohistochemistry. The correlation between clinical features of DLBCL and tumor-related index were analyzed. Cox regression was conducted to explore risk factors and hazard ratio. RESULTS: The serum level or expressions of VEGF, IL-8, IL-10, and RIP2 were significantly elevated with the increase of Ann Arbor Stage, International Prognostic Index (IPI) scores, Eastern Cooperative Oncology Group (ECOG) scores, serum lactate dehydrogenase (LDH) level, and the number of extranodal sites (all P < 0.05). Beside, these serum indexes were significantly higher in patients with the presence of extranodal involvement and germinal center B-cell (GCB), but significantly lower in patients with the presence of bone marrow involvement (all P < 0.05). Cox regression analysis for overall survival revealed that high expression of VEGF, high level of serum IL-8, serum IL-10, and RIP2, Ann Arbor Stage (III-IV), number of extranodal sites (>1), serum LDH level (≥245 U/L), IPI scores (3–5), ECOG scores (≥2), and bone marrow involvement were independent risk factors for the prognosis of DLBCL patients (all P < 0.05). CONCLUSION: The serum levels of VEGF, IL-8, and IL-10, as well as the expression of RIP2 and PIK3CA in tumor tissues, were highly correlated to clinical features of DLBCL, and high expression level of these indexes may have adverse effects for the prognosis of DLBCL patients. Hindawi 2022-12-07 /pmc/articles/PMC9750766/ /pubmed/36567775 http://dx.doi.org/10.1155/2022/2637581 Text en Copyright © 2022 Na Shen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Na
Yu, Yanfang
Zhang, Ruiying
Guo, Ying
Liu, Mei
Tan, Mengtian
Liu, Jianxia
Bai, Jing
Li, Li
Liu, Keyu
Wang, Ran
He, Jinglan
Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
title Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
title_full Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
title_fullStr Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
title_full_unstemmed Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
title_short Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
title_sort expression and prognostic value of pik3ca, vegf, il-8, il-10, and rip2 in diffuse large b-cell lymphoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750766/
https://www.ncbi.nlm.nih.gov/pubmed/36567775
http://dx.doi.org/10.1155/2022/2637581
work_keys_str_mv AT shenna expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT yuyanfang expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT zhangruiying expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT guoying expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT liumei expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT tanmengtian expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT liujianxia expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT baijing expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT lili expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT liukeyu expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT wangran expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma
AT hejinglan expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma